DarioHealth Corp. Common Stock (DRIO) is a publicly traded Healthcare sector company. As of July 6, 2026, DRIO trades at $7.12 with a market cap of $53.23M and a P/E ratio of 1.33. DRIO moved +0.00% today. Year to date, DRIO is -30.60%; over the trailing twelve months it is -48.73%. Its 52-week range spans $5.84 to $31.00. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces DRIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DarioHealth Secures Arizona Insurer ASO Deal via Amwell Covering Hundreds of Thousands: DarioHealth signed an agreement with a major Arizona insurer via Amwell to offer its cardiometabolic digital health program to the insurer’s ASO book covering hundreds of thousands of lives. The program, backed by over 100 studies, yields up to 5x ROI with fewer hospitalizations and improved blood pressure and A1C.
| Metric | Value |
|---|---|
| Price | $7.12 |
| Market Cap | $53.23M |
| P/E Ratio | 1.33 |
| EPS | $5.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.00 |
| 52-Week Low | $5.84 |
| Volume | 2.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $21.19M |
| Net Income | $-40.74M |
| Gross Margin | 56.55% |
2 analysts cover DRIO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.